Back
Royalty Pharma PLC Stock Price Chart

This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
RPRX
Royalty Pharma PLC
Last Price:
$35.61
Seasonality Move:
-5.97%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and RPRX is experiencing slight buying pressure.
Royalty Pharma PLC Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.01 | Buy |
20-day SMA: | 35.71 | Buy |
50-day SMA: | 34.22 | Buy |
200-day SMA: | 30.63 | Buy |
8-day EMA: | 28.13 | Buy |
20-day EMA: | 16.28 | Buy |
50-day EMA: | 7.69 | Buy |
200-day EMA: | 2.1 | Buy |
Royalty Pharma PLC Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 9.51 | Buy |
Relative Strength Index (14 RSI): | 63.23 | Buy |
Chaikin Money Flow: | 866835 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (34.59 - 36.23) | Buy |
Bollinger Bands (100): | (31.98 - 34.82) | Buy |
Royalty Pharma PLC Technical Analysis
Jul 1 | Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
01 | 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Royalty Pharma PLC Stock
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 36.51 while RPRX 8-day simple moving average is 36.01, which is a Buy signal.
-
The stock price of RPRX is 36.51 while Royalty Pharma PLC 20-day SMA is 35.71, which makes it a Buy.
-
Royalty Pharma PLC 50-day simple moving average is 34.22 while RPRX share price is 36.51, making it a Buy technically.
-
RPRX stock price is 36.51 and Royalty Pharma PLC 200-day simple moving average is 30.63, creating a Buy signal.
RPRX Technical Analysis vs Fundamental Analysis
Sell
39
Royalty Pharma PLC (RPRX)
is a Sell
Is Royalty Pharma PLC a Buy or a Sell?
-
Royalty Pharma PLC stock is rated a SellThe current Royalty Pharma PLC [RPRX] share price is $36.51. The Score for RPRX is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Royalty Pharma PLC Stock Info
Market Cap:
15.4B
Price in USD:
36.51
Share Volume:
2.8M
Royalty Pharma PLC 52-Week Range
52-Week High:
36.69
52-Week Low:
24.05
Sell
39
Royalty Pharma PLC (RPRX)
is a Sell
Royalty Pharma PLC Share Price Forecast
-
What is the Royalty Pharma PLC stock price today?The Royalty Pharma PLC stock price is 36.51 USD today.
-
Will RPRX stock go up or go down?Royalty Pharma PLC> share price is forecast to RISE/FALL based on technical indicators
-
Is Royalty Pharma PLC overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Royalty Pharma PLC is overvalued.
Is Royalty Pharma PLC Stock a Buy?
-
Royalty Pharma PLC share price is 36.51 while RPRX 8-day exponential moving average is 28.13, which is a Buy signal.
-
The stock price of RPRX is 36.51 while Royalty Pharma PLC 20-day EMA is 16.28, which makes it a Buy.
-
Royalty Pharma PLC 50-day exponential moving average is 7.69 while RPRX share price is 36.51, making it a Buy technically.
-
RPRX stock price is 36.51 and Royalty Pharma PLC 200-day simple moving average is 2.10, creating a Buy signal.
Fundamental Analysis of Royalty Pharma PLC
Is Royalty Pharma PLC a good investment?
-
Analysts estimate an earnings increase this quarter of $0.11 per share, an increase next quarter of $0.38 per share, an increase this year of $0.35 per share, and an increase next year of $0.63 per share.
Technical Analysis of Royalty Pharma PLC
Should I short Royalty Pharma PLC stock?
-
RPRX Moving Average Covergence Divergence (MACD) indicator is 9.51, suggesting Royalty Pharma PLC is a Buy
-
Royalty Pharma PLC Relative Strength Index (RSI) is 63.23, which suggest Royalty Pharma PLC is overbought
-
The Bollinger Bands (25) for Royalty Pharma PLC is (34.59 - 36.23), which suggest Royalty Pharma PLC is a Buy
-
The Bollinger Bands (100) for Royalty Pharma PLC is (31.98 - 34.82), which suggest Royalty Pharma PLC is a Buy
* Royalty Pharma PLC stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.